Who invested in Allozyne?
Allozyne's investors include ARCH Venture Partners, MPM Capital, OVP Venture Partners, Amgen and Alexandria Real Estate Equities.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$37Mraised across 4 rounds since 2005, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $900K sold, first sale Mar 2013
No investor was named in the report.
Reported by sec.govSEC filing: $2.5M sold, first sale Jan 2012
Reported by allbusiness.com
Reported by goodwinprocter.com
From the SEC filings it signed: 2 on the team.
On the board, as filediCarl WeissmanDavid TirrellMichael SteinmetzSteven Gillis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Allozyne's investors include ARCH Venture Partners, MPM Capital, OVP Venture Partners, Amgen and Alexandria Real Estate Equities.
Allozyne has raised $37M across 4 rounds since 2005.
Allozyne's most recent round was a Debt of $900K in Apr 2013.
Allozyne's largest round on record is $30M (Series B), in Oct 2007.
Allozyne's first round on record, in Dec 2005, was backed by ARCH Venture Partners, MPM Capital and OVP Venture Partners and 1 others.
Allozyne's latest named round is a Debt, in Apr 2013.
Allozyne is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.